S

Secura Bio

Commercializes oncology therapies and develops COPIKTRA

Key Account Manager

Field SalesPosted on Nov 10
Full-timeRemote in USA$185k - $226kRemote

About the Job

Requirements

  • A Bachelor's degree in Life Sciences, Business, Marketing, or a related field is required.
  • At least 8 years of successful pharmaceutical or biotechnology sales experience is required.
  • A proven track record of achieving or exceeding sales targets is required.
  • Experience calling on Medical Oncologists, Hematologists, and/or oncology practices is required.
  • Experience launching new products or promoting products in competitive markets is required.
  • Ability to understand, retain, and communicate complex clinical, efficacy, and safety data is required.
  • A strong grasp of oncology/hematology disease states and treatment paradigms is required.
  • Ability to engage in scientific discussions with highly trained medical professionals is required.
  • Experience in strategic territory planning and business plan development is required.
  • Strong analytical skills to assess territory opportunities and track performance metrics are required.
  • A thorough understanding of pharmaceutical industry regulations, including FDA, PhRMA Code, and OIG guidelines, is required.
  • Commitment to ethical selling practices and promoting products within approved indications is required.
  • Excellent presentation and public speaking skills are required.
  • Ability to travel 50% or more to meet customers, attend conferences, training, and meetings is required.
  • Ability to work effectively with cross-functional teams, including Medical Affairs, Market Access, and Marketing, is required.

Responsibilities

  • Promote Copiktra and other approved drugs consistently with approved indications and company policies to targeted customers, including Medical Oncologists, Hematologists, and multidisciplinary teams.
  • Improve customer awareness and on-label sales of Copiktra throughout the assigned territory.
  • Engage cross-functional partners, including Market Development Managers, the Market Access team, and Medical Science Liaisons, to meet customer needs and ensure customer questions are appropriately addressed.
  • Educate appropriate healthcare providers on the on-label use of Copiktra in a fair and balanced manner, delivering clinical, efficacy, and safety messaging using company-approved promotional materials.
  • Develop and execute comprehensive territory business plans aligned with corporate strategic objectives to achieve sales targets and key performance metrics.
  • Conduct monthly business reviews to analyze progress, identify opportunities and risks, and implement data-driven adjustments.
  • Conduct face-to-face interactions at all assigned territory accounts.
  • Achieve on-label sales growth in accordance with business plans and Secura Bio policies.
  • Monitor operating costs and manage the territory budget.
  • Identify key practice decision-makers at each account and conduct promotional presentations, informational in-services, and educational programs for targeted customers.
  • Support commercial presence at appropriate key medical congresses in the territory.
  • Engage Medical Science Liaisons or another designated Medical Affairs contact for appropriate follow-up on customer questions.
  • Comply with Secura Bio policies and applicable laws.
  • Travel overnight within the territory for face-to-face customer interactions, conferences, training, and sales meetings.

Desired Qualifications

  • An advanced degree (MBA, MS, PharmD, or a related discipline) is preferred.

About the Company

Secura Bio

Commercializes oncology therapies and develops COPIKTRA

Secura Bio is an integrated biopharmaceutical company focused on bringing oncology therapies to patients. Its main product is COPIKTRA (duvelisib), an oral PI3K inhibitor used to treat adults with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The company is also running a Phase 3 study of COPIKTRA for relapsed or refractory nodal T-follicular helper cell lymphoma. Secura Bio’s approach centers on acquiring, developing, and commercializing approved and late-stage oncology assets, with headquarters in Las Vegas and a European office in Dublin. In simple terms, the company buys or develops cancer drugs and then brings them to doctors and patients who need them. Its goal is to close the gap between available oncology therapies and the patients who can benefit from them.

Company size
51-200
Company stage
Late Stage VC
Total funding
$55M
Headquarters
Berkeley Heights, NJ
Founded
2019

Recently Posted Jobs

Explore more opportunities at Secura Bio

See more jobs